QQQ   426.72 (+0.21%)
AAPL   167.42 (-0.35%)
MSFT   409.31 (-0.61%)
META   509.16 (+3.03%)
GOOGL   155.85 (+0.24%)
AMZN   181.81 (+0.29%)
TSLA   150.23 (-3.36%)
NVDA   860.27 (+2.37%)
AMD   156.16 (+1.39%)
NIO   4.01 (+2.56%)
BABA   69.31 (+0.71%)
T   16.20 (+0.50%)
F   12.10 (+0.50%)
MU   112.88 (-2.97%)
GE   156.64 (+0.62%)
CGC   7.75 (+19.41%)
DIS   113.59 (+0.58%)
AMC   2.94 (-1.34%)
PFE   25.33 (-0.35%)
PYPL   62.61 (-1.03%)
XOM   118.93 (+0.25%)
QQQ   426.72 (+0.21%)
AAPL   167.42 (-0.35%)
MSFT   409.31 (-0.61%)
META   509.16 (+3.03%)
GOOGL   155.85 (+0.24%)
AMZN   181.81 (+0.29%)
TSLA   150.23 (-3.36%)
NVDA   860.27 (+2.37%)
AMD   156.16 (+1.39%)
NIO   4.01 (+2.56%)
BABA   69.31 (+0.71%)
T   16.20 (+0.50%)
F   12.10 (+0.50%)
MU   112.88 (-2.97%)
GE   156.64 (+0.62%)
CGC   7.75 (+19.41%)
DIS   113.59 (+0.58%)
AMC   2.94 (-1.34%)
PFE   25.33 (-0.35%)
PYPL   62.61 (-1.03%)
XOM   118.93 (+0.25%)
QQQ   426.72 (+0.21%)
AAPL   167.42 (-0.35%)
MSFT   409.31 (-0.61%)
META   509.16 (+3.03%)
GOOGL   155.85 (+0.24%)
AMZN   181.81 (+0.29%)
TSLA   150.23 (-3.36%)
NVDA   860.27 (+2.37%)
AMD   156.16 (+1.39%)
NIO   4.01 (+2.56%)
BABA   69.31 (+0.71%)
T   16.20 (+0.50%)
F   12.10 (+0.50%)
MU   112.88 (-2.97%)
GE   156.64 (+0.62%)
CGC   7.75 (+19.41%)
DIS   113.59 (+0.58%)
AMC   2.94 (-1.34%)
PFE   25.33 (-0.35%)
PYPL   62.61 (-1.03%)
XOM   118.93 (+0.25%)
QQQ   426.72 (+0.21%)
AAPL   167.42 (-0.35%)
MSFT   409.31 (-0.61%)
META   509.16 (+3.03%)
GOOGL   155.85 (+0.24%)
AMZN   181.81 (+0.29%)
TSLA   150.23 (-3.36%)
NVDA   860.27 (+2.37%)
AMD   156.16 (+1.39%)
NIO   4.01 (+2.56%)
BABA   69.31 (+0.71%)
T   16.20 (+0.50%)
F   12.10 (+0.50%)
MU   112.88 (-2.97%)
GE   156.64 (+0.62%)
CGC   7.75 (+19.41%)
DIS   113.59 (+0.58%)
AMC   2.94 (-1.34%)
PFE   25.33 (-0.35%)
PYPL   62.61 (-1.03%)
XOM   118.93 (+0.25%)

Enlivex Therapeutics (ENLV) SEC Filings & 10K Form

$1.42
-0.07 (-4.39%)
(As of 12:17 PM ET)

Recent Enlivex Therapeutics SEC Filings

DateFilerForm TypeView
04/16/2024
7:00 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2024
7:13 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/29/2024
3:30 PM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/07/2024
7:02 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/22/2024
7:00 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/17/2024
7:02 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/20/2023
7:01 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/07/2023
3:30 PM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/26/2023
3:30 PM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/18/2023
7:00 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/13/2023
3:42 PM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/11/2023
7:00 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/01/2023
3:30 PM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/02/2023
7:05 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/31/2023
7:05 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/26/2023
7:03 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/31/2023
7:09 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/08/2023
7:02 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/19/2023
7:03 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ENLV) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners